Residents came together to deliver thousands of cards, gifts, and thoughtful notes for one very special little boy.

Data from DELIVER and ACHIEVE Clinicals Trial to be Presented - - Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker ...

Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of ...

The Galesburg Fire Department (GFD) really came through for people with neuromuscular diseases at the annual Fill the Boot Campaign. The department ranked second in Illinois for dollars collected ...

Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...

HAYWARD, Calif. - Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company with a market capitalization of $225 million, announced today that it will present interim data from its ...

On March 18 th Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will be giving an oral presentation in the first session dedicated to OPMD at the 2025 Muscular ...

Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...